Published in Vaccine on February 25, 2010
Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun (2010) 1.04
Outer membrane vesicles as platform vaccine technology. Biotechnol J (2015) 0.80
A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial. J Infect (2015) 0.80
An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity. PLoS One (2015) 0.75
Eco1-dependent cohesin acetylation during establishment of sister chromatid cohesion. Science (2008) 3.72
Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science (2009) 3.68
Transposon-like Correia elements: structure, distribution and genetic exchange between pathogenic Neisseria sp. FEBS Lett (2002) 3.27
Making 'sense' of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol (2005) 3.20
Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science (2010) 3.10
PorA variable regions of Neisseria meningitidis. Emerg Infect Dis (2004) 3.08
Modulation of Shigella virulence in response to available oxygen in vivo. Nature (2010) 2.96
Optimization of virulence functions through glucosylation of Shigella LPS. Science (2005) 2.81
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81
F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity (2012) 2.72
Development of vaccines against meningococcal disease. Lancet (2002) 2.67
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology (2003) 2.62
Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat Rev Microbiol (2009) 2.62
Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun (2004) 2.44
Functional significance of factor H binding to Neisseria meningitidis. J Immunol (2006) 2.39
Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet (2006) 2.30
Regulatory control of the resolution of DNA recombination intermediates during meiosis and mitosis. Cell (2011) 2.08
Hos1 deacetylates Smc3 to close the cohesin acetylation cycle. Mol Cell (2010) 1.92
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One (2010) 1.90
Identification of pathogen-specific genes through microarray analysis of pathogenic and commensal Neisseria species. Microbiology (2005) 1.88
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine (2012) 1.81
Interactions between Neisseria meningitidis and the complement system. Trends Microbiol (2007) 1.72
Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect Dis (2009) 1.67
Tracking airborne Legionella and Legionella pneumophila at a biological treatment plant. Environ Sci Technol (2008) 1.58
Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol (2010) 1.54
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci U S A (2009) 1.53
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine (2008) 1.53
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine. Clin Diagn Lab Immunol (2005) 1.51
CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability. Mol Cell (2010) 1.51
Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods. J Clin Microbiol (2012) 1.50
Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol (2007) 1.44
Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist (2006) 1.43
Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis. Mol Microbiol (2002) 1.40
[Infections in immunosuppressed children]. Tidsskr Nor Laegeforen (2005) 1.39
Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair. Mol Cell (2012) 1.37
Role of Neisseria meningitidis luxS in cell-to-cell signaling and bacteremic infection. Infect Immun (2002) 1.36
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J Clin Microbiol (2009) 1.32
Available carbon source influences the resistance of Neisseria meningitidis against complement. J Exp Med (2005) 1.30
A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med (2008) 1.30
Architecture of the major component of the type III secretion system export apparatus. Nat Struct Mol Biol (2012) 1.24
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One (2012) 1.23
Differential control of Eg5-dependent centrosome separation by Plk1 and Cdk1. EMBO J (2011) 1.22
Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine (2008) 1.21
Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol (2011) 1.18
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine (2005) 1.17
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci U S A (2013) 1.16
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood (2003) 1.14
An outbreak of legionnaires disease caused by long-distance spread from an industrial air scrubber in Sarpsborg, Norway. Clin Infect Dis (2008) 1.13
Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med (2007) 1.13
Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vaccine (2010) 1.11
Neisseria meningitidis lactate permease is required for nasopharyngeal colonization. Infect Immun (2005) 1.11
DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. Nature (2012) 1.11
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLoS Pathog (2012) 1.10
Temperature triggers immune evasion by Neisseria meningitidis. Nature (2013) 1.10
Neisseria lactamica protects against experimental meningococcal infection. Infect Immun (2002) 1.09
Role of bacterial endotoxin in chronic heart failure: the gut of the matter. Shock (2007) 1.07
Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis. Infect Immun (2005) 1.06
Epidemiological evidence for the role of the hemoglobin receptor, hmbR, in meningococcal virulence. J Infect Dis (2009) 1.05
Phenotypic and genotypic characterization of Streptococcus pneumoniae strains colonizing children attending day-care centers in Norway. J Clin Microbiol (2008) 1.03
A role for the RNA pol II-associated PAF complex in AID-induced immune diversification. J Exp Med (2012) 1.03
Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines. Microbiology (2008) 1.01
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing. Vaccine (2008) 1.01
Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics (2006) 1.00
Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae. Infect Immun (2006) 0.99
Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol (2009) 0.99
Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence. Microbiology (2011) 0.99
Sequence conservation of pilus subunits in Neisseria meningitidis. Vaccine (2010) 0.98
Growth deficiencies of Neisseria meningitidis pfs and luxS mutants are not due to inactivation of quorum sensing. J Bacteriol (2008) 0.98
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989. J Clin Microbiol (2006) 0.98
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Hum Vaccin (2007) 0.95
Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium. Infect Immun (2010) 0.95
Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates. Infect Immun (2013) 0.95
Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell Microbiol (2012) 0.95
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine (2005) 0.93
Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry. Hum Vaccin (2005) 0.93
4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins. Haematologica (2009) 0.92
The human heart proteome: Two-dimensional maps using narrow-range immobilised pH gradients. Electrophoresis (2006) 0.92
Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines. Vaccine (2005) 0.91
Arginine methylation of the c-Jun coactivator RACO-1 is required for c-Jun/AP-1 activation. EMBO J (2013) 0.91
Identification of meningococcal genes necessary for colonization of human upper airway tissue. Infect Immun (2008) 0.91
Effect of host lactate on gonococci and meningococci: new concepts on the role of metabolites in pathogenicity. Infect Immun (2007) 0.90
Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine. Infect Immun (2003) 0.89
Variation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptor. Microbiology (2010) 0.89
Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect Immun (2004) 0.89
Mechanisms of meningococcal colonisation. Trends Microbiol (2011) 0.89
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Rev Vaccines (2011) 0.88
Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J Infect Dis (2002) 0.88
The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. PLoS One (2010) 0.88
The leukemia-associated Rho guanine nucleotide exchange factor LARG is required for efficient replication stress signaling. Cell Cycle (2014) 0.88
Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences. BMC Genomics (2014) 0.88
Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies. Infect Immun (2009) 0.87